This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Nuance Unveils ICD-10-Ready Platform For Computer-Assisted Coding And Clinical Documentation Improvement At AHIMA

AHIMA CONFERENCE-- Nuance Communications, Inc. (NASDAQ: NUAN) today announced a significant enhancement to its Clintegrity 360 platform that integrates clinical documentation improvement (CDI) and computer-assisted coding (CAC) into one seamless process. This single, web-based solution creates a natural and efficient way for clinicians to create more complete and accurate clinical documentation, while supporting downstream revenue cycle and quality reporting processes. Nuance Clintegrity 360 will be demonstrated in booth #1226 at the 2013 American Health Information Management Association (AHIMA) Convention & Exhibits October 27 – 30.

A Single Platform for CAC, CDI and Regulatory Compliance

Healthcare organizations can now efficiently manage these complex initiatives with a single intelligent system that integrates advanced technology, workflows and information in a meaningful way, connecting physicians, clinical documentation improvement specialists and coders to help drive clinical accuracy, compliance and revenue integrity from end-to-end. Powered by Nuance’s Clinical Language Understanding (CLU) technology, Clintegrity 360 provides computer-assisted solutions for coders, CDI specialists and physicians.

“With the increasing pressure healthcare provider organizations are feeling from ICD-10, Meaningful Use and various forms of value-based reimbursement and medical necessity requirements, customers are rethinking their entire clinical documentation chain,” said Peter Durlach, senior vice president of marketing, product management & strategy, Nuance. “In this new era of healthcare, clinical documentation is playing an even more strategic role in the delivery and reimbursement of high quality care, and our Clintegrity 360 platform is designed to help our customers operate successfully in this new environment.”

Clintegrity’s single platform provides:

  • ICD-9 and ICD-10 Computer-Assisted Coding & Compliance – Computer-assisted coding and compliance for inpatient and outpatient settings enables providers to improve coder productivity up to 89 percent, reduce time-to-bill up to 80 percent and improve overall coding accuracy. With Clintegrity 360™ | Computer-Assisted Coding, provider organizations can educate their coders on ICD-10 in real-time by having the system automatically suggest both ICD-9 and ICD-10 codes for the same patient case. In addition, the solution automatically highlights the evidence used in selecting codes and maintains an audit trail to support compliance, quality and auditing requirements.
  • Computer-Assisted CDI – By combining Nuance’s core CLU technology with the proven J.A. Thomas clinical CDI guidelines and program, Clintegrity 360 also delivers computer-assisted CDI to help organizations achieve higher quality care, more appropriate reimbursement, and enhanced medical necessity compliance while also improving CDI team productivity with auto-suggested high-value clarifications.
  • Computer-Assisted Physician Documentation – This enables organizations to automatically prompt physicians in real-time with high confidence CDI clarifications directly within their electronic health record’s (EHR) native physician documentation workflow. Because these clarifications are automatically presented at the point of documentation, physicians learn how to document more appropriately, and this improves their responses rates and satisfaction while the productivity of the CDI team can also increase by as much as 50 percent.
  • Shared Visibility and Communication about Patient Cases – Clintegrity enables coders to have a real-time view into the complete CDI process for more accurate and concurrent coding. Additionally, coders and CDI team members share a common view of the patient case, and can communicate within Clintegrity – thereby improving coding throughput and accuracy while minimizing disruptive physician queries.

For more information on Nuance Clintegrity 360, visit: www.nuance.com. Connect with Nuance on social media through the healthcare blog, For the Health of IT, as well as Twitter and Facebook.

About Nuance Communications, Inc.

Nuance Communications, Inc. (NASDAQ: NUAN) is a leading provider of voice and language solutions for businesses and consumers around the world. Its technologies, applications and services make the user experience more compelling by transforming the way people interact with devices and systems. Every day, millions of users and thousands of businesses experience Nuance’s proven applications. For more information, please visit: www.nuance.com.

Nuance and the Nuance logo are trademarks or registered trademarks of Nuance Communications, Inc. or its affiliates in the United States and/or other countries. All other company names or product names may be the trademarks of their respective owners.

The statements in this press release relating to future plans, events or services, are forward-looking statements which are subject to specific risks and uncertainties. There are a number of factors which could cause actual events or results to differ materially from those indicated in such forward looking statements, including fluctuations in demand for the Nuance products, and the continued development of Nuance products. The reader is warned not to rely on these forward-looking statements without reservation, since these are simply reflections of the current situation. Nuance disclaims any obligation to update any forward-looking statements as a result of developments occurring after the date of this document.

Copyright Business Wire 2010

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,563.30 -317.06 -1.88%
S&P 500 1,930.67 -39.40 -2.00%
NASDAQ 4,369.7730 -93.1290 -2.09%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs